Paydirt
RCKT
Ticker

Rocket Pharmaceuticals, Inc.

RCKT · Healthcare · Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, ma…

Rocket Pharmaceuticals, Inc. (RCKT), in the Healthcare sector, has 3 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 0 purchases and 3 sales. Filers took a median of 4 days from execution to disclosure, and the most recent trade was executed Sep 11 and filed Sep 16. The most active filer was Gaurav Shah with 4 filings.

Add to watchlist
Filings, ttm
3
0 buys · 3 sells
Traders, ttm
3
3 insiders
Volume, ttmiDollar value disclosed in the window
$557K
estimated for Congress, as filed for insiders
Median delay
4d
execution to disclosure
Last traded
Sep 11
Filed Sep 15
ADViAverage daily dollar volume
$8.0M
market data
Share price · 12M
$3.37 (+6.0%)
$5.30$3.95$2.60Sep 22 2025Mar 23Sep 18

Adjusted for splits and dividends.

Volume by month
$256K$128K$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · sells $145KFeb 2025 · sells $172KApr 2025 · buys $102KMay 2026 · sells $172KAug 2026 · sells $128KSep 2026 · sells $256K
Buys $102K Sells $874K

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
GS Gaurav Shah CEO 4 filings CS Christopher James Stevens Chief Operating Officer 1 filing MW Martin Wilson General Counsel 1 filing
Recent filings
Martin WilsonSALE General Counsel $256K
75,364 sh × $3.40
Exec Sep 11
Filed Sep 15 · 8:27 PM ET
Christopher James StevensSALE Chief Operating Officer $128K
36,658 sh × $3.50
Exec Aug 11
Filed Aug 13 · 4:15 PM ET
Gaurav ShahSALE CEO $172K
55,684 sh × $3.09
Exec May 21
Filed May 26 · 5:30 PM ET
Gaurav ShahPURCHASE CEO $102K
20,000 sh × $5.08
Exec Apr 10 2025
Filed Apr 14 2025 · 5:30 PM ET
Gaurav ShahSALE CEO $172K
16,303 sh × $10.58
Exec Feb 21 2025
Filed Feb 25 2025 · 5:30 PM ET
Gaurav ShahSALE CEO $145K
11,091 sh × $13.05
Exec Nov 21 2024
Filed Nov 25 2024 · 5:30 PM ET